Evidence map›Paper›PMID 35448406›Full record

ArticleMembranes2022

Effect of the Incorporation of ZIF-8@GO into the Thin-Film Membrane on Salt Rejection and BSA Fouling.

Elizabeth Gaobodiwe Masibi, Thollwana Andretta Makhetha, Richard Motlhaletsi Moutloali

Abstract read
In one paragraph

Article in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Dual-functionalization of amine-ZIF-8 and sulfone-GO for improved flux, antifouling, and rejection performance of thin film composite membrane.Water science and technology : a journal of the International Association on Water Pollution Research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizabeth Gaobodiwe MasibiDepartment of Chemical Sciences, Faculty of Science, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.
Thollwana Andretta MakhethaDepartment of Chemical Sciences, Faculty of Science, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.
Richard Motlhaletsi MoutloaliDSI/Mintek Nanotechnology Innovation Centre-UJ Water Research Node, University of Johannesburg, P.O. Box 17011, Doornfontein, Johannesburg 2028, South Africa.ORCID 0000-0002-2965-5241

Funding

Department of Science and Innovation/Mintek Nanotechnology Innovation Centre Not applicable
6 · The paper itself

Abstract

A series of Zeolitic imidazole framework-8 (ZIF-8) clusters supported on graphene oxide (ZIF-8@GO) nanocomposites were prepared by varying the ratios of ZIF-8 to GO. The resultant nanocomposites were characterized using various techniques, such as Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM), X-ray diffraction (XRD), Brunauer-Emmett-Teller (BET), thermogravimetric analysis (TGA), Fourier Transform Infrared (FTIR) and Raman spectroscopy. These nanocomposites were incorporated into the thin film layer during interfacial polymerisation process of m-phenylenediamine (aqueous phase which contained the dispersed nanocomposites) and trimesoyl chloride (TMC, organic phase) at room temperature onto polyethersulfone (PES) ultrafiltration (UF) support membrane. The membrane surface morphology, cross section and surface roughness were characterized using SEM and AFM, respectively. Compared to the baseline membranes, the thin film nanofiltration (TFN) membranes exhibited improved pure water flux (from 1.66 up to 7.9 L.m

Indexed as

graphene oxideinterfacial polymerizationnanofiltrationthin film composite membraneszeolitic imidazole framework-8

Identifiers

PMID35448406
PMCPMC9027943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.